Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Share:

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2009, Vol. 14 ›› Issue (12): 1400-1402.

Previous Articles     Next Articles

Clinical observation of sodium selenite combination prednisone treatment on subacute thyroiditis

XIA Li-bin, LU Mei-qin, ZHANG Bin-hua, ZHANG An-su, CHEN Yue-ping, ZHAO Yong-li, HUA Qiang, HE Chun-ling   

  1. Department of Endocrinology, Yijishan Hospital, Wannan Medical College, Wuhu 241000, Anhui, China
  • Received:2009-10-26 Revised:2009-11-29 Published:2020-10-20

Abstract: AIM: To investigate the effects of sodium selenite combination prednisone in patients with subacute thyroiditis( SAT).METHODS: 78 cases of SAT were studied with a randomized controlled prospective study from Sep 2004 to Aug 2008 in our hospital.In control group, 2 cases were lost, 37 patients were completed the observation, the treatment group were 39 cases.Prednisone was treated in both groups, sodium selenite was served in treatment group, with a total course of about 8 weeks.RESULTS: After 8 weeks of treatment, the erythrocyte sedimentation rate ( ESR) of sodium selenite group was lower than that of control group at 2th and 4th weeks ( P <0.05), 131 I uptake rate of sodium selenite group was higher than that of control group at 2 h, 6 h and 24 h ( P < 0.01), while the relapse rate was lower than that of the control group ( P <0.05).CONCLUSION: The sodium selenite can shorten the course of subacute thyroiditis and reduce the relapse rate.

Key words: sodium selenite, subacute thyroiditis(SAT), erythrocyte sedimentation rate ( ESR), 131 I uptake rate

CLC Number: